tiprankstipranks
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Ownership - Who Owns Madrigal Pharmaceuticals?

Compare
1,164 Followers

Madrigal Pharmaceuticals (MDGL) Ownership Overview

19.56%27.43%0.07%14.90%38.03%
19.56% Insiders
0.07% Other Institutional Investors
14.90% ETFs
38.03% Public Companies and Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 42.41% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 38.03% is owned by Public Companies and Individual Investors.
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 27.50% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 14.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 27, 2025
xxxxxxxxxxxxx
$116328
Jan 27, 2025
William John Sibold
President & Ceo,director
xxxxxxxxxxxxx
$531020
Jan 27, 2025
Rebecca Taub
Pres., R&d, And Cmo,director
xxxxxxxxxxxxx
$217236
Jan 27, 2025
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$34530

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,042,000Institution9.36%688,562,400
1,974,590Institution9.05%665,831,748
1,794,831Insider8.23%605,217,013
1,621,976Institution7.44%546,930,307
1,608,624Institution7.38%542,428,013
1,583,921Institution7.26%534,098,161
1,112,202Insider5.10%375,034,514
841,989Insider3.86%283,918,691
828,781Institution3.80%279,464,953
392,297Institution1.80%132,282,548

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,608,624Institution7.38%542,428,013
1,583,921Institution7.26%534,098,161
272,634Institution1.25%91,932,185
219,753Institution1.01%74,100,712
211,019Institution0.97%71,155,607
198,711Institution0.91%67,005,349
191,446Institution0.88%64,555,591
189,988Institution0.87%64,063,954
135,295Institution0.62%45,621,474
112,700Institution0.52%38,002,440

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
515,684Institution2.36%159,124,612
482,614Institution2.21%162,737,441
416,579Institution1.91%128,543,782
355,663Institution1.63%125,090,234
276,599Institution1.27%85,350,153
258,866Institution1.19%79,878,282
160,344Institution0.74%54,067,997
114,880Institution0.53%38,737,536
85,376Institution0.39%26,344,472
81,952Institution0.38%28,823,338

FAQ

Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 19.56% is held by insiders, and 38.03% is held by retail investors.
    What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.07% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors.
      What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 38.03% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors.
        Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
        John Paulson owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis